Finasteride Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Dosage (1mg, 5mg); Application (Prostate Enlargement, Prostate Cancer, Scalp Hair Loss, Excessive Hair Growth, Hormone Therapy, Others); Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies)

Report Code: TIPRE00021686 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Finasteride medicine is used to treat benign prostatic hyperplasia and hair loss in men. It may be prescribed alone or in combination with other medicines to treat the symptoms of benign prostatic hyperplasia, which will further eliminate the need for surgery. Oral finasteride helps in scalp hair growth and further prevents hair loss in men.

MARKET DYNAMICS

The finasteride market is expected to grow owing to growing prevalence of BPH (benign prostatic hyperplasia), rising geriatric population and increasing hair loss issues in men. Moreover, product approvals and increasing research and development initiatives may create growth opportunities for the market.

MARKET SCOPE

The "Finasteride Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of finasteride market with detailed market segmentation by dosage, application, and distribution channel. The finasteride market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in finasteride market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The finasteride market is segmented on the basis of dosage, application, and distribution channel. Based on dosage, the market is segmented as 1mg, and 5mg. Based on application, the market is segmented as prostate enlargement, prostate cancer, scalp hair loss, excessive hair growth, hormone therapy, and others. The distribution channel segment is segmented into retail pharmacies, online pharmacies, and hospital pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the finasteride market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The finasteride market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting finasteride market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the finasteride market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the finasteride market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from finasteride market are anticipated to have lucrative growth opportunities in the future with the rising demand for finasteride market in the global market. Below mentioned is the list of few companies engaged in the finasteride market.

The report also includes the profiles of key players in finasteride market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Zhejiang CONBA Pharmaceutical
  •   Merck
  •   Cipla
  •   Sandoz
  •   Teva Pharmaceuticals
  •   RelonChem
  •   Henan Topfond
  •   Actavis
  •   Accord Pharmaceuticals
  •   Mylan N.V.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Finasteride Market - By Dosage
1.3.2 Finasteride Market - By Application
1.3.3 Finasteride Market - By Distribution Channel
1.3.4 Finasteride Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. FINASTERIDE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. FINASTERIDE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. FINASTERIDE MARKET - GLOBAL MARKET ANALYSIS
6.1. FINASTERIDE - GLOBAL MARKET OVERVIEW
6.2. FINASTERIDE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. FINASTERIDE MARKET - REVENUE AND FORECASTS TO 2028 - DOSAGE
7.1. OVERVIEW
7.2. DOSAGE MARKET FORECASTS AND ANALYSIS
7.3. 1MG
7.3.1. Overview
7.3.2. 1mg Market Forecast and Analysis
7.4. 5MG
7.4.1. Overview
7.4.2. 5mg Market Forecast and Analysis
8. FINASTERIDE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PROSTATE ENLARGEMENT
8.3.1. Overview
8.3.2. Prostate Enlargement Market Forecast and Analysis
8.4. PROSTATE CANCER
8.4.1. Overview
8.4.2. Prostate Cancer Market Forecast and Analysis
8.5. SCALP HAIR LOSS
8.5.1. Overview
8.5.2. Scalp Hair Loss Market Forecast and Analysis
8.6. EXCESSIVE HAIR GROWTH
8.6.1. Overview
8.6.2. Excessive Hair Growth Market Forecast and Analysis
8.7. HORMONE THERAPY
8.7.1. Overview
8.7.2. Hormone Therapy Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. FINASTERIDE MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Retail Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
9.5. HOSPITAL PHARMACIES
9.5.1. Overview
9.5.2. Hospital Pharmacies Market Forecast and Analysis
10. FINASTERIDE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Finasteride Market Overview
10.1.2 North America Finasteride Market Forecasts and Analysis
10.1.3 North America Finasteride Market Forecasts and Analysis - By Dosage
10.1.4 North America Finasteride Market Forecasts and Analysis - By Application
10.1.5 North America Finasteride Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Finasteride Market Forecasts and Analysis - By Countries
10.1.6.1 United States Finasteride Market
10.1.6.1.1 United States Finasteride Market by Dosage
10.1.6.1.2 United States Finasteride Market by Application
10.1.6.1.3 United States Finasteride Market by Distribution Channel
10.1.6.2 Canada Finasteride Market
10.1.6.2.1 Canada Finasteride Market by Dosage
10.1.6.2.2 Canada Finasteride Market by Application
10.1.6.2.3 Canada Finasteride Market by Distribution Channel
10.1.6.3 Mexico Finasteride Market
10.1.6.3.1 Mexico Finasteride Market by Dosage
10.1.6.3.2 Mexico Finasteride Market by Application
10.1.6.3.3 Mexico Finasteride Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Finasteride Market Overview
10.2.2 Europe Finasteride Market Forecasts and Analysis
10.2.3 Europe Finasteride Market Forecasts and Analysis - By Dosage
10.2.4 Europe Finasteride Market Forecasts and Analysis - By Application
10.2.5 Europe Finasteride Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Finasteride Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Finasteride Market
10.2.6.1.1 Germany Finasteride Market by Dosage
10.2.6.1.2 Germany Finasteride Market by Application
10.2.6.1.3 Germany Finasteride Market by Distribution Channel
10.2.6.2 France Finasteride Market
10.2.6.2.1 France Finasteride Market by Dosage
10.2.6.2.2 France Finasteride Market by Application
10.2.6.2.3 France Finasteride Market by Distribution Channel
10.2.6.3 Italy Finasteride Market
10.2.6.3.1 Italy Finasteride Market by Dosage
10.2.6.3.2 Italy Finasteride Market by Application
10.2.6.3.3 Italy Finasteride Market by Distribution Channel
10.2.6.4 Spain Finasteride Market
10.2.6.4.1 Spain Finasteride Market by Dosage
10.2.6.4.2 Spain Finasteride Market by Application
10.2.6.4.3 Spain Finasteride Market by Distribution Channel
10.2.6.5 United Kingdom Finasteride Market
10.2.6.5.1 United Kingdom Finasteride Market by Dosage
10.2.6.5.2 United Kingdom Finasteride Market by Application
10.2.6.5.3 United Kingdom Finasteride Market by Distribution Channel
10.2.6.6 Rest of Europe Finasteride Market
10.2.6.6.1 Rest of Europe Finasteride Market by Dosage
10.2.6.6.2 Rest of Europe Finasteride Market by Application
10.2.6.6.3 Rest of Europe Finasteride Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Finasteride Market Overview
10.3.2 Asia-Pacific Finasteride Market Forecasts and Analysis
10.3.3 Asia-Pacific Finasteride Market Forecasts and Analysis - By Dosage
10.3.4 Asia-Pacific Finasteride Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Finasteride Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Finasteride Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Finasteride Market
10.3.6.1.1 Australia Finasteride Market by Dosage
10.3.6.1.2 Australia Finasteride Market by Application
10.3.6.1.3 Australia Finasteride Market by Distribution Channel
10.3.6.2 China Finasteride Market
10.3.6.2.1 China Finasteride Market by Dosage
10.3.6.2.2 China Finasteride Market by Application
10.3.6.2.3 China Finasteride Market by Distribution Channel
10.3.6.3 India Finasteride Market
10.3.6.3.1 India Finasteride Market by Dosage
10.3.6.3.2 India Finasteride Market by Application
10.3.6.3.3 India Finasteride Market by Distribution Channel
10.3.6.4 Japan Finasteride Market
10.3.6.4.1 Japan Finasteride Market by Dosage
10.3.6.4.2 Japan Finasteride Market by Application
10.3.6.4.3 Japan Finasteride Market by Distribution Channel
10.3.6.5 South Korea Finasteride Market
10.3.6.5.1 South Korea Finasteride Market by Dosage
10.3.6.5.2 South Korea Finasteride Market by Application
10.3.6.5.3 South Korea Finasteride Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Finasteride Market
10.3.6.6.1 Rest of Asia-Pacific Finasteride Market by Dosage
10.3.6.6.2 Rest of Asia-Pacific Finasteride Market by Application
10.3.6.6.3 Rest of Asia-Pacific Finasteride Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Finasteride Market Overview
10.4.2 Middle East and Africa Finasteride Market Forecasts and Analysis
10.4.3 Middle East and Africa Finasteride Market Forecasts and Analysis - By Dosage
10.4.4 Middle East and Africa Finasteride Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Finasteride Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Finasteride Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Finasteride Market
10.4.6.1.1 South Africa Finasteride Market by Dosage
10.4.6.1.2 South Africa Finasteride Market by Application
10.4.6.1.3 South Africa Finasteride Market by Distribution Channel
10.4.6.2 Saudi Arabia Finasteride Market
10.4.6.2.1 Saudi Arabia Finasteride Market by Dosage
10.4.6.2.2 Saudi Arabia Finasteride Market by Application
10.4.6.2.3 Saudi Arabia Finasteride Market by Distribution Channel
10.4.6.3 U.A.E Finasteride Market
10.4.6.3.1 U.A.E Finasteride Market by Dosage
10.4.6.3.2 U.A.E Finasteride Market by Application
10.4.6.3.3 U.A.E Finasteride Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Finasteride Market
10.4.6.4.1 Rest of Middle East and Africa Finasteride Market by Dosage
10.4.6.4.2 Rest of Middle East and Africa Finasteride Market by Application
10.4.6.4.3 Rest of Middle East and Africa Finasteride Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Finasteride Market Overview
10.5.2 South and Central America Finasteride Market Forecasts and Analysis
10.5.3 South and Central America Finasteride Market Forecasts and Analysis - By Dosage
10.5.4 South and Central America Finasteride Market Forecasts and Analysis - By Application
10.5.5 South and Central America Finasteride Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Finasteride Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Finasteride Market
10.5.6.1.1 Brazil Finasteride Market by Dosage
10.5.6.1.2 Brazil Finasteride Market by Application
10.5.6.1.3 Brazil Finasteride Market by Distribution Channel
10.5.6.2 Argentina Finasteride Market
10.5.6.2.1 Argentina Finasteride Market by Dosage
10.5.6.2.2 Argentina Finasteride Market by Application
10.5.6.2.3 Argentina Finasteride Market by Distribution Channel
10.5.6.3 Rest of South and Central America Finasteride Market
10.5.6.3.1 Rest of South and Central America Finasteride Market by Dosage
10.5.6.3.2 Rest of South and Central America Finasteride Market by Application
10.5.6.3.3 Rest of South and Central America Finasteride Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL FINASTERIDE MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. FINASTERIDE MARKET, KEY COMPANY PROFILES
13.1. SHANDONG RENHETANG PHARMACEUTICAL
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. MERCK
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. CIPLA
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SANDOZ
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. TEVA PHARMACEUTICALS
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. RELONCHEM
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. HENAN TOPFOND
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ACTAVIS
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ACCORD PHARMACEUTICALS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MYLAN N.V.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Zhejiang CONBA Pharmaceutical
2. Merck
3. Cipla
4. Sandoz
5. Teva Pharmaceuticals
6. RelonChem
7. Henan Topfond
8. Actavis
9. Accord Pharmaceuticals
10. Mylan N.V.
TIPRE00021686
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking